Keywords: vismed, enters, trial, dry, eye, syndrome, usa-based

Vismed enters US trial for dry eye syndrome

Article | 22 January 2007

Print This

USA-based drug development firm Lantibio and Swiss pharmaceutical company TRB Chemedica have initiated a Phase III clinical trial of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in